Zobrazeno 1 - 10
of 203
pro vyhledávání: '"V, Schwoebel"'
Autor:
V Schwoebel
Publikováno v:
Indian Journal of Tuberculosis. 67:S33-S42
Surveillance of tuberculosis is one of the oldest disease surveillance systems in the world. This article briefly reviews its history, describes its methods and main results, with a specific focus on low- and middle-income countries, and underlines i
Autor:
E Masserey, Anne Detjen, M Adjobimey, A G Wandji, Stephen M. Graham, C Delacourt, S Gnanou, Arnaud Trébucq, P Mselatti, K G Koura, Alberto Roggi, J-C Gody, V Schwoebel
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 24:452-460
SETTING: The largest cities in Benin, Burkina Faso, Cameroon and Central African Republic.OBJECTIVE: To demonstrate the feasibility and document the effectiveness of household contact investigation and preventive therapy in resource-limited settings.
Autor:
P. Gueudet, D. Diulius, A. Beaumont, H. Aumaître, Harold Noel, M. Ledrans, M. Médus, C. Durand, V. Schwoebel, L. Colombain
Publikováno v:
Infectious Diseases Now
Europe PubMed Central
Europe PubMed Central
Introduction La pandémie de Covid-19 est apparue comme un révélateur des inégalités sociales de santé. En mars 2020, de nombreux cas ont été déclarés dans trois quartiers défavorisés où vit une importante communauté gitane. Une étude d
Autor:
Lutgarde Lynen, Nimer Ortuno-Gutierrez, Bouke C. de Jong, Alberto Roggi, Mourtala Mohamed Assao-Neino, Tom Decroo, Alphazazi Soumana, Mahamadou Bassirou Souleymane, Saidou Mamadou, Assiatou Gagara-Issoufou, Souleymane Hassane-Harouna, Ibrahim Mamane Lawan, Armand Van Deun, V Schwoebel, Zelika Hamidou-Harouna, Alberto Piubello
Publikováno v:
The European respiratory journal. 57(1)
The short treatment regimen (STR) achieves a >80% cure in rifampicin-resistant tuberculosis (RR-TB) patients. However, ototoxicity induced by the injectable is a concern. This is the first study to evaluate the replacement of injectables by linezolid
Autor:
K G Koura, V Schwoebel, Armand Van Deun, Tom Decroo, Arnaud Trébucq, Alberto Piubello, Chen Yuan Chiang
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1, p 55 (2019)
Journal of Clinical Medicine, Vol 9, Iss 1, p 55 (2019)
About ten years ago, the first results of the so-called “Bangladesh regimen”, a short regimen lasting nine months instead of 20 months, revolutionized multidrug-resistant tuberculosis (MDR-TB) treatment. Similar short regimens were studied in dif
Autor:
Arnaud Trébucq, Alberto Piubello, V Schwoebel, Bouke C. de Jong, Hans L. Rieder, Armand Van Deun, Tom Decroo, Chen Yuan Chiang, Sabira Tahseen, Nimer Ortuno-Gutierrez
Publikováno v:
International journal of antimicrobial agents. 55(1)
The 2018 World Health Organization (WHO) treatment guidelines for multidrug-/rifampicin-resistant tuberculosis (MDR/RR-TB) give preference to all-oral long regimens lasting for 18-20 months. The guidelines strongly recommend combining bedaquiline, le
Autor:
V Schwoebel, K G Koura, E Heldal, A. Van Deun, C. Y. Chiang, Arnaud Trébucq, Alberto Piubello, Hans L. Rieder, Nadia Aït-Khaled
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 23(5)
sec id="st1"titleOBJECTIVE/titleTo assess whether the revised 2013 World Health Organization (WHO) definitions for multidrug-resistant tuberculosis (MDR-TB) treatment outcomes apply to shorter treatment regimens in low- and middle-income countries an
Autor:
Anthony D. Harries, L N Patel, J P K Nyengele, Nadia Aït-Khaled, C-Y Chiang, J. Tonsing, I Syed, Srinath Satyanarayana, J-P Dongo, I. Monedero-Recuero, I. D. Rusen, V Zamora, A S Thu, Yan Lin, R Nyinoburyo, Thet Ko Aung, V Schwoebel, J. Caminero Luna, Riitta A Dlodlo, T Sanda, Arnaud Trébucq, Alberto Piubello, Francesca Conradie, Sarabjit Chadha, Nay Lynn Oo, Ajay M. V. Kumar, C. Zishiri, R. T. Ncube, E Heldal, P. I. Fujiwara, Sven Gudmund Hinderaker, Stephen M. Graham, K G Koura, A Nakanwagi-Mukwaya, Alberto Roggi, N. Mlilo, Paul M. Jensen
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 23(2)
People living with the human immunodeficiency virus (HIV) (PLHIV) are at high risk for tuberculosis (TB), and TB is a major cause of death in PLHIV. Preventing TB in PLHIV is therefore a key priority. Early initiation of antiretroviral therapy (ART)
Autor:
E Masserey, G Gbénagnon, Séverin Anagonou, C Adjonou, M Adjobimey, Jean-Pierre Zellweger, V Schwoebel
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 20:1055-1059
SETTINGS Two large tuberculosis (TB) centres under a well-functioning National TB Programme (NTP) in Benin, West Africa. OBJECTIVE To assess the feasibility and results of integrating a programme of isoniazid preventive therapy (IPT) in children aged
Autor:
Hans L. Rieder, Armand Van Deun, V Schwoebel, Arnaud Trébucq, Alberto Piubello, Chen Yuan Chiang
Publikováno v:
European Respiratory Journal. 55:2000718
The first step to reduce the risk of creating an epidemic of bedaquiline-resistant TB entails addressing the lack of access to rapid fluoroquinolone drug susceptibility testing in a high proportion of MDR-/RR-TB in low- and middle-income countrieshtt